# | ||||
---|---|---|---|---|
1 | DEVANI Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response | 2008 | 5˙923˙577.00 | 4˙196˙460.00 |
2 | EIMID-IAPP European Initiative for basic research in Microbiology and Infectious Diseases - IAPP | 2008 | 2˙172˙806.00 | 2˙172˙806.00 |
3 | MEGALOVAX In search of new cytomegalovirus vaccine antigens | 2010 | 164˙958.00 | 164˙958.00 |
4 | EIMID ITN European Initiative for basic research in Microbiology and Infectious Diseases | 2010 | 2˙662˙577.00 | 2˙662˙577.00 |
5 | TCDIFLU Impact of adjuvants on T cell differentiation after Influenza Vaccination analyzed at the Single Cell Level | 2011 | 180˙084.00 | 180˙084.00 |
6 | RESTAVAC Regulation of Expression of Staphylococcus aureus Vaccine Antigen Candidates | 2013 | 179˙739.00 | 179˙739.00 |
7 | SV-STAPH-VAX Structural Vaccinology to drive the design and optimization of protein antigens for a multicomponent vaccine against Staphylococcus aureus | 2014 | 187˙414.00 | 187˙414.00 |
8 | SAMUFLU Self-amplifying RNA technology applied to the development of a universal influenza vaccine | 2014 | 187˙414.00 | 187˙414.00 |
9 | DISCO A multidisciplinary Doctoral Industrial School on novel preventive strategies against E. Coli infections | 2014 | 1˙009˙587.00 | 1˙009˙587.00 |
L'Ente glaxosmithkline vaccines srl partecipato anche in questi progetti.